Tags: Jimmy Carter | testosterone | cancer | FDA

New Treatments to Control Cancer

By Thursday, 31 December 2015 12:25 PM Current | Bio | Archive

Some months ago, former President Jimmy Carter announced at his local Sunday school meeting that he had developed a melanoma that had spread to his liver. He also reported that there we two malignancies in his brain.

Based on the data we have, Carter’s prognosis would have been thought to be dire. But just a few months later, he announced that based on current imaging technology and other studies, he can say that he is cancer-free.

Carter was treated with surgical removal of the area in the liver, received radiation therapy to the two parts of his brain, and was also placed on a drug called Opvivo that has recently been approved by the FDA for treatment of melanoma. The fact that he can now say that he is cancer-free indicates a changing pattern of cancer treatment.

There are also now data that showing up on television about Opvivo for treatment of squamous non-small cell lung cancer. In fact, it is being touted as significantly increasing survival rates.

This drug is the first FDA-approved immune treatment for cancer — and it is, in all probability, the opening of a whole new area of cancer treatment programs.

In the past, we have seen the occasional patient who has beat the odds with current cancer therapy. One example is the story of General John Bruce Medaris, the man who supervised the launching of the first space satellite.

As General Medaris was retiring from the Air Force, he developed prostate cancer; a few months later, he was discovered to have fairly extensive bone metastasis from the prostate cancer. His urologist gave him six months to live.

Through his contacts with NASA, General Medaris was referred by Werner Von Braun to my brother’s hospital clinic in Dallas, Texas. There, we had significant experience using radioactive phosphorus (P32) and testosterone for treatment of metastatic bone cancer. General Medaris elected to undergo treatment. He said, at that time, that if he lived five more years, he would become an Episcopal priest.

With one course of the P32 and testosterone, the pain in his bones cleared, the bones themselves returned to an essentially normal pattern. Five years later, still doing well from the treatment Bruce Medaris went into the Episcopal priesthood program. After becoming an Episcopal priest, he was able to practice for 17 years, dying from cardiac problems 25 years after his six month life prognosis.

Unfortunately, the technology of the P32 plus testosterone to treat bone metastatis has dropped by the wayside for no good reason except possibly cost: The radioactive therapy that is used to treat metastatic bone cancer today costs 4 to 5 times as much per course.

When considering treatment of cancer today, there is the growing recognition of the value of nutritional therapy. In fact, there are a number of books now on the market describing methods for treating cancer naturally, including Bill Henderson’s “How to Cure Almost Any Cancer at Home for $5.15 a Day,” “The Stingler Cancer-Reversing Protocol” by Mark Stingler, M.D., and “31- Day Home Cancer Cure” by Ty Bollinger and Andy Scholberg.

With these natural methods and the new technologies of utilizing immune programs for cancer treatment, there is a significant chance we will be able to do a much better job of controlling cancer in the near future than what has been the outcomes in the past.

© 2020 NewsmaxHealth. All rights reserved.

1Like our page
With natural methods and the new technologies of utilizing immune programs for cancer treatment, there is a significant chance we will be able to do a much better job of controlling cancer.
Jimmy Carter, testosterone, cancer, FDA
Thursday, 31 December 2015 12:25 PM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved